Sweta Modi
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
Papers in
-
- Nanoparticle-Based Drug Delivery 5
-
- Drug Solubulity and Delivery Systems 4
- Advanced Drug Delivery Systems 2
- Co-authors
- Bradley D. Anderson (3 shared papers)Neeraj Kumar (5 shared papers)Jay Prakash Jain (5 shared papers)Abraham J. Domb (3 shared papers)Xiaoxia Lin (1 shared paper)Christodoulos A. Floudas (1 shared paper)Tian‐Xiang Xiang (1 shared paper)Manthena V. S. Varma (3 shared papers)
- Journals
- Journal of Controlled Release (2 papers)Drug Metabolism and Disposition (2 papers)Pharmaceutical Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- United StatesIndiaIsrael
In The Last Decade
Sweta Modi
12 papers receiving 659 citations
Peers
Comparison fields: 5 of 101
- Pharmaceutical Science 151
- Biomaterials 285
- Pharmacology 57
- Industrial and Manufacturing Engineering 54
- Molecular Medicine 22
Countries citing papers authored by Sweta Modi
This map shows the geographic impact of Sweta Modi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sweta Modi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sweta Modi more than expected).
Fields of papers citing papers by Sweta Modi
This network shows the impact of papers produced by Sweta Modi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sweta Modi. The network helps show where Sweta Modi may publish in the future.
Co-authors
The 21 scholars most cited alongside Sweta Modi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 230 | |
| 2 | 2005 | 118 | |
| 3 | 2002 | 74 | |
| 4 | 2012 | 55 | |
| 5 | 2006 | 51 | |
| 6 | 2018 | 40 | |
| 7 | 2018 | 35 | |
| 8 | 2007 | 24 | |
| 9 | 2018 | 20 | |
| 10 | 2006 | 15 | |
| 11 | 2013 | 12 | |
| 12 | 2005 | 5 |
About Sweta Modi
Sweta Modi is a scholar working on Biomaterials, Pharmaceutical Science, Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology, having authored 12 papers that have together received 679 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Drug Solubulity and Delivery Systems (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Lipid Membrane Structure and Behavior (2 papers), Advanced Drug Delivery Systems (2 papers), HIV/AIDS drug development and treatment (2 papers) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Pharmaceutical Science (151 citations), Biomaterials (285 citations), Pharmacology (57 citations), Industrial and Manufacturing Engineering (54 citations) and Molecular Medicine (22 citations). Sweta Modi has collaborated with scholars based in United States, India and Israel. Frequent co-authors include Bradley D. Anderson, Neeraj Kumar, Jay Prakash Jain, Abraham J. Domb, Xiaoxia Lin, Christodoulos A. Floudas, Tian‐Xiang Xiang, Manthena V. S. Varma, Rachel E. Kosa and A. David Rodrigues. Their work appears in journals such as Journal of Controlled Release, Drug Metabolism and Disposition, Pharmaceutical Research, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.